Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-19-000024
Filing Date
2019-08-06
Accepted
2019-08-06 16:52:04
Documents
92
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20190630x10q.htm   iXBRL 10-Q 1683159
2 EXHIBIT 10.2 ex06302019102.htm EX-10.2 803004
3 EXHIBIT 31.1 ex06302019311.htm EX-31.1 18456
4 EXHIBIT 31.2 ex06302019312.htm EX-31.2 18551
5 EXHIBIT 32.1 ex06302019321.htm EX-32.1 11257
6 EXHIBIT 32.2 ex06302019322.htm EX-32.2 11429
12 leasefootprinta03.jpg GRAPHIC 50201
13 pipelinechartq22019a03.jpg GRAPHIC 79172
  Complete submission text file 0001438533-19-000024.txt   8750048

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20190805.xsd EX-101.SCH 52239
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20190805_cal.xml EX-101.CAL 99600
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20190805_def.xml EX-101.DEF 236252
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20190805_lab.xml EX-101.LAB 669778
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20190805_pre.xml EX-101.PRE 409222
14 EXTRACTED XBRL INSTANCE DOCUMENT rtrx-20190630x10q_htm.xml XML 1249334
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 191002833
SIC: 2834 Pharmaceutical Preparations